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The outer membrane of Gram-negative bacteria contains phos-
pholipids and lipopolysaccharide (LPS) in the inner and outer leaf-
let, respectively. Little is known about the transport of the phospho-
lipids from their site of synthesis to the outer membrane. The inner
membrane protein MsbA of Escherichia coli, which is involved in
the transport of LPS across the inner membrane, has been reported
to be involved in phospholipid transport as well. Here, we have
reported the construction and the characterization of a Neisseria
meningitidis msbAmutant. The mutant was viable, and it showed a
retarded growthphenotype and contained very lowamounts of LPS.
However, it produced an outer membrane, demonstrating that
phospholipid transport was not affected by the mutation. Notably,
higher amounts of phospholipids were produced in the msbA
mutant than in its isogenic parental strain, provided that capsular
biosynthesis was also disrupted. Although these results confirmed
that MsbA functions in LPS transport, they also demonstrated that
it is not required for phospholipid transport, at least not in
N. meningitidis.
The cell envelope of Gram-negative bacteria consists of an inner
(IM)4 and an outer membrane (OM) separated by the peptidoglycan-
containing periplasm. The IM is a phospholipid (PL) bilayer, whereas
the OM is asymmetrical, with PL and lipopolysaccharide (LPS) mole-
cules located in the inner and outer leaflet, respectively. Escherichia coli
has three major PL species, phosphatidylethanolamine, phosphatidylg-
lycerol (PG), and cardiolipin (CL), and their synthesis takes place at the
cytoplasmic side of the IM (1). The mechanism of transport of these
amphiphilic molecules from their site of synthesis across the aqueous
periplasm to the OM is only poorly understood.
Recently, a role for the MsbA protein in PL transport was suggested
(2, 3). The msbA gene was first identified in E. coli as a multicopy sup-
pressor of a mutation in the htrB (lpxL) gene, which encodes an enzyme
involved in a late step of the biosynthesis of lipid A (4, 5), a structural
component of LPS (6). Subsequently, it was demonstrated that LPS
accumulated in the IM of a temperature-sensitive msbA mutant at the
restrictive temperature (2) and that it was not accessible to periplasmic
modifications under those conditions (3), demonstrating that MsbA
catalyzes the trans-bilayer movement of LPS. Interestingly, it was
observed that in the temperature-sensitivemsbAmutant, newly synthe-
sized PL also accumulated in the IM at the restrictive temperature (2)
and that they were poorly accessible to membrane-impermeable
reagents under those conditions (3). These results strongly suggest that
MsbA is involved not only in LPS transport but also in PL transport.
However, as indicated (3), the possibility that LPS accumulation on the
inner surface of the IM interferes with PL transport by some other
mechanismcannot be excluded. Furthermore, it has been demonstrated
that the flip-flop of PL in bilayers is strongly induced by the introduction
of either model trans-membrane -helical peptides or IM proteins (7).
It was postulated that a subset of proteins, characterized by a small
number of trans-membrane helices, facilitates lipid translocation via the
protein-lipid interface, thereby eliminating the need for a dedicated PL
flippase (8). Interestingly, in contrast to several other integral IM pro-
teins, MsbA reconstituted in proteoliposomes did not stimulate PL flip-
flop (7). However, it remained a possibility thatMsbAwas not function-
ally reconstituted in these experiments.
Since a role forMsbA in PL transport is not entirely clear, we decided
to study this issue in vivo inNeisseria meningitidis. In contrast to E. coli,
this bacterium is not dependent on LPS synthesis since an lpxAmutant,
lacking the first enzyme required for LPS biosynthesis, was viable and
still produced anOM (9). Recently, we already exploited this property of
N. meningitidis to demonstrate that the OM protein designated Imp,
which is essential in E. coli (10), has a role in LPS transport (11). Thus,
we anticipated that it would be possible to inactivate themsbA gene in
N. meningitidis if the corresponding protein had a role in LPS transport
only and not in PL transport. In this report, we have described anmsbA
mutant in N. meningitidis.
MATERIALS ANDMETHODS
Bacterial Strains and Growth Conditions—N.meningitidesH44/76 is
a serogroup B strain from our laboratory collection. The imp (11) and
lpxAmutant strains (9) are derivatives of this strain. HB-1 is a capsule-
deficient mutant of H44/76 (12). The N. meningitidis strains were
grown in candle jars at 37 °C on GC agar (BD Biosciences) plates con-
taining 2%Vitox (Oxoid) and antibiotics (kanamycin, 100g/ml; chlor-
amphenicol, 5g/ml) when appropriate. Liquid cultures were grown in
tryptic soy broth in plastic flasks at 37 °C with aeration. E. coli strains
DH5 (13) and Top10F (Invitrogen) were used for routine cloning
procedures. The temperature-sensitive msbA mutant strain WD2 (2)
was a generous gift of the Raetz laboratory. E. coli strains were grown on
LB agar plates or in liquid LB medium (14). Kanamycin (50 g/ml) or
chloramphenicol (25g/ml) was addedwhen appropriate. Experiments
with genetically modified organisms were performed under license
number GGO 99-139.
Construction of Plasmids and msbA Mutant Strains—We made use
of the available genome sequence ofN. meningitidis strainMC58 (15) to
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design PCR primers. For complementation experiments, we amplified
themsbA gene fromH44/76 genomic DNA by PCR with primers E and
F (Fig. 1) with sequences 5-TTCATATGATAGAAAAACTGACTT-
TCGG-3 (NdeI restriction site is underlined) and 5-GACGTC-
CCATTTCGGACGGCATTTTGT-3 (AatII restriction site is under-
lined), respectively, using the High Fidelity kit (Roche Applied Science)
according to themanufacturer’s protocol. The PCR product was cloned
into pCRII-TOPO (Invitrogen), and after NdeI and AatII restriction,
ligated into pEN11 (11), resulting in plasmid pEN11-msbA. pEN11 is
derived from pEN10 by introduction of a NotI cassette, containing an
erythromycin-resistance gene, the lac repressor, and a tandem lac oper-
ator/promoter segment (erm lacIOP) (16). ThemsbAmutant derivative
of H44/76 (see below) was transformed with pEN11-msbA by co-incu-
bation of bacteria with plasmid and 5mMMgCl2 for 6 h on plate. Trans-
formants were subsequently selected on plates containing chloram-
phenicol and repeatedly streaked on plates containing 100 M
isopropyl--D-thiogalactopyranoside before performing complementa-
tion experiments.
To disrupt the msbA gene in N. meningitidis, parts of the genes
upstream and downstream of msbA, designated NMB1918 and
NMB1920, respectively, were amplified by PCR from genomic DNA of
H44/76 using Taq polymerase. Primers A and B (Fig. 1) with sequences
5-CCCAAAGCGAAGTGGTCGAA-3 and 5-GTCGACTATCGG-
TAGGGCGGGAACTG-3 (AccI restriction site is underlined), respec-
tively, were used to amplify the upstream region, whereas primers C and
D with sequences 5-GTCGACGACCGCATCATCGTGATGGA-3
(AccI restriction site is underlined) and 5-TTCGTCGCTGCCGAC-
CTGTT-3, respectively, were used to amplify the downstream region.
Both PCR products were cloned into pCRII-TOPO, resulting in plas-
mids pCRII-NMB1918 and pCRII-NMB1920, respectively. An AccI-
KpnI fragment of pCRII-NMB1918 was ligated into AccI-KpnI-di-
gested pCRII-NMB1920. The resulting plasmid was cut with AccI to
allow for the insertion of a kanamycin-resistance cassette derived from
pMB25 (11). The final construct, called pBT-msbA::kan, contained the
kanamycin resistance cassette in the same orientation as originally the
msbA gene andwas used as the template for amplification of the disrup-
tion fragment by PCRwith primer pair A/D (Fig. 1). Approximately 200
ng of this PCR product was added together with 5mMMgCl2 to H44/76
or HB-1 bacteria that were subsequently grown on plate for 6 h. Here-
after, bacteria were transferred to plates containing kanamycin. The
correct gene replacement in kanamycin-resistant transformants was
confirmed by PCR using primer pair A/D. All enzymes were purchased
from Fermentas, except where indicated otherwise.
Subcellular Localization of PL and LPS in WD2 Cells—WD2 cells
containing either pEN11-msbA or the empty vector pEN10 were
pregrown at 30 °C and diluted to an optical density at 600 nm (A600) of
0.01. After further growth at 30 °C until the A600 reached1, 8 ml of
the culture were diluted into 32 ml of prewarmedmedium, and incuba-
tion was continued at 44 °C for 30 min. The cells were subsequently
labeled for 10 min with 40 Ci of [1-14C]sodium acetate and thereafter
cooled rapidly on ice, collected, turned into spheroplasts, and finally
sonicated as described (2). Samples were loaded on top of a sucrose
gradient (17), and after centrifugation at 38,000 rpm for 22.5 h in an
SW41 rotor (BeckmanCoulter), 12 fractions of 1mlwere collected from
top to bottom of the gradient. PLwere directly isolated (18) from 200-l
samples of each fraction, whereas lipid A was isolated (19) after precip-
itation of LPS with trichloroacetic acid from 500-l samples. The
amounts of the radiolabeled PL and lipid A were determined by liquid
scintillation counting in a 1209 Rackbeta LSC (LKB Wallac). Lactate
dehydrogenase activity (20) was used as an IMmarker. Total amount of
LPS molecules, visualized by silver staining after SDS-PAGE (21), was
used as a marker for the OM.
Analysis of PL Content—Cells grown overnight on plate were har-
vested and resuspended in 5ml of tryptic soy broth to anA550 of 0.1. The
cells were labeled for 7 h with 2 Ci of [1-14C]sodium acetate at 37 °C.
Phospholipids were isolated (18) from 1.4 ml of culture. Equal amounts
(1000 counts/minute) of radioactive phospholipids were loaded onto
TLCplates (silica gel 60, 20 10 cm,Merck). The plateswere developed
with chloroform/methanol/acetic acid at a ratio of 65:25:10, subjected
to autoradiography, and exposed to a PhosphorImager screen (Amer-
sham Biosciences). Spots were subsequently quantified with a Personal
Molecular Imager FX (Bio-Rad).
For quantitative analysis of the total PL content, cells were harvested
fromplate andwashedwith a buffer containing 0.238% free acidHEPES,
0.04% KCl, 0.85% NaCl, 0.01% MgCl2.6H2O, 0.09% anhydrous glucose,
and 0.5 mM CaCl2, adjusted with NaOH to pH 7.4. Phospholipids were
isolated (18), and their amount was quantified by determining the phos-
phorus content (22).
LPS Analysis—For LPS analysis,3.105 cells (based upon the estima-
tion that an A550 of 1 represents 1.109 cells/ml) were boiled in SDS-
PAGE sample buffer and subsequently incubated with 0.5 mg/ml pro-
teinase K at 55 °C for 1 h. After boiling for 10min, lysates were analyzed
on Tricine-SDS-PAGE gels (23) containing 16% acrylamide and stained
with silver (21). Cell envelopes were isolated as described previously
(24). The LPS content of cell envelopes was determined by 3-deoxy-D-
manno-octulosonic acid (KDO) measurement as described (25).
Protein Analysis—SDS-PAGE under denaturing or semi-native con-
ditions and immunoblotting were performed as described (24). For
denaturing conditions, samples were boiled in SDS-PAGE sample
buffer containing 2% SDS and 2.5%-mercaptoethanol prior to electro-
phoresis, whereas for semi-native conditions, the sample buffer con-
tained only 0.1% SDS and no -mercaptoethanol, and the samples were
not heated prior to electrophoresis. Protein concentrations from cell
envelopes were measured using the BCA protein assay kit (Pierce)
according to the manufacturer’s protocol.
FIGURE 1. Genetic organization of the msbA locus in the wild-type strain and the constructed msbAmutant. The kanamycin resistance cassette (KAN) replaces msbA in the
mutant, leaving only 131 bp at the 3 end (M). Primers used for the disruption procedure and cloning of msbA are indicated with arrowheads. The predicted promoter (P) and
terminator (T) sequences are indicated. Open reading frames indicated with NMB1918 and NMB1920 putatively code for a malonyl CoA-acyl carrier protein transacylase and GMP
synthase, respectively. A–F, primer sites as described under “Materials and Methods.”
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Electron Microscopy—Cells were harvested from plate and chemi-
cally fixed, embedded in gelatin, and cryosectioned as described (26).
Ultrathin sections were observed with a Technai 10 electron micro-
scope at 100 kV.
RESULTS
The genome of N. meningitidis strain MC58 (15) was searched with
the default search matrix of the tBlastn program (27) using the amino
acid sequence of E. coliMsbA as a probe (www.ncbi.nlm.nih.gov/blast).
The amino acid sequence of the putative MsbA protein encoded by the
meningococcal geneNMB1919 displayed 32% identity and 52% similar-
ity to that of E. coliMsbA. The NMB1919 gene was then cloned, and we
investigated whether this Neisserial gene could complement an E. coli
msbA mutation. The growth of the E. coli K-12 temperature-sensitive
msbAmutant strain WD2 is arrested at 44 °C (2). When pEN11-msbA,
containing themsbA gene ofN. meningitidis, was introduced intoWD2,
growth was fully restored at 44 °C to wild-type levels (data not shown).
Moreover, whereas de novo synthesized phospholipids (Fig. 2A) and
LPS (Fig. 2B) accumulated at 44 °C in the IM of strainWD2 carrying the
empty vector, consistent with previous results (2), the localization of
these compounds to the OMwas restored when the strain was comple-
mented with the Neisserial msbA gene (Fig. 2A, B) and did not deviate
from that observed in the wild-type strain grown at 44 °C (data not
shown). Thus, the Neisserial MsbA protein could functionally substi-
tute for E. coliMsbA.
Gene replacement was used to constructmsbAmutant derivatives of
N. meningitidis strain H44/76 and of its capsule-deficient derivative
HB-1 (Fig. 1). Kanamycin-resistant transformants were analyzed by
PCR to verify the absence of an intact copy of the msbA gene and the
presence of themsbA::kan allele (data not shown). Since correct trans-
formants were obtained at high frequency, it appears that in N. menin-
gitidis, in contrast to E. coli (28), MsbA is not essential for viability. The
results described below were essentially the same for themsbAmutants
created in both parent strains, unless stated otherwise. We have not
directly analyzed the expression of the genes adjacent to msbA in the
msbA::kan mutants, but the complementation studies performed
revealed full complementation with no signs of side effects.
The generation time of the msbA mutants was strongly increased
during exponential growth, i.e. from60min for the parental strains to
120min for themutants, and the cultures did not reach the same final
OD (A550 of 3.2 as opposed to 5.9 for the parental strains). After 16 h of
growth at 37 °C on plates, the colonies of the msbA mutants were
smaller than those of the parental strains, and they also had an opaque
appearance, in contrast to those formed by the wild-type strains (data
not shown). Similar phenotypes have been described also forN. menin-
gitidismutants defective in other LPS biogenesis genes, i.e. the lpxA and
imp mutants (11). Growth on plates at 30 and 42 °C did not reveal a
temperature-sensitive phenotype of the msbA, lpxA, and imp mutants
(data not shown).
To investigate whether MsbA, as in E. coli, plays a role in LPS trans-
port in N. meningitidis, proteinase K-treated cell lysates from both the
wild type and the msbAmutants were analyzed by Tricine-SDS-PAGE
(Fig. 3A). Although LPS could clearly be detected on the gels in the cell
lysate from the wild-type strain (Fig. 3A, lane 1), it was not visible in that
of the msbA mutant strain (Fig. 3A, lane 3). Since a putative transcrip-
tional terminator is present immediately downstream of themsbA gene
(Fig. 1), the decreased LPS content in themsbAmutant was expected to
be a direct consequence of the inactivation of themsbA gene and not of
any polar effect of the mutation on downstream-located genes. This
supposition was confirmed in a complementation experiment. Almost
normal levels of LPS were observed when the msbA mutant was com-
plemented with pEN11-msbA, a plasmid carrying the wild-type msbA
gene (Fig. 3A, lane 2). Apparently, the msbA mutation has a strong
impact on LPS synthesis, possibly due to some feedback inhibition
mechanism caused by LPS stalled in the transport pathway, as observed
previously in the imp mutant (11). To quantify the LPS content, we
determined the amount of KDO, a structural component typical for
LPS. Cell envelopes of the msbA mutant cells contained an LPS-to-
protein ratio similar to that in the imp mutant and of only 7% when
compared with wild-type cells (Fig. 3B). When plasmid pEN11-msbA
was introduced into the msbA mutant, the LPS-to-protein ratio was
restored to nearly wild-type levels (Fig. 3B). Taken together, these
results confirmed a role of MsbA in LPS biogenesis in N. meningitidis.
To determine whether the msbA mutants still possess an OM, we
prepared ultrathin sections of the cells and examined them by electron
microscopy (Fig. 4A). Indeed, a double membrane was clearly visible,
demonstrating that both IM and OM were still present. Additionally,
FIGURE 2. Localization of de novo synthesized PL and LPS in temperature-sensitive
msbAmutant WD2 complemented with NeisserialmsbA.WD2 cells carrying pEN11-
msbA (solid line) or the empty vector (dashed line) were grown for 30 min at 44 °C and
subsequently labeledwith [14C]acetate. After separation of themembranes on a sucrose
gradient, 12 fractions of 1 ml were taken, and PL and lipid A were isolated from each
fraction. The amount of radiolabeled PL (A) and lipid A (B) in each fraction was deter-
mined by liquid scintillation counting and is represented as the percentage of the total
counts. Theprocedure always resulted in a clear separationof IMandOMas illustratedby
the fractionationof the IMmarker lactate dehydrogenase (LDH, indicated as thepercent-
age of total activity in C) and of the OM marker LPS, detected by silver staining after
SDS-PAGE (D), in a representative experiment.
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analysis of the cell envelope protein profiles indicated that the expres-
sion of the major OM proteins PorA and PorB is not compromised in
the msbA mutant (data not shown). Analysis of cell envelopes under
non-denaturing conditions revealed that the PorA protein was mostly
present in its trimeric form, although, as in the imp and lpxAmutants, a
small amount of monomeric PorA was detected in the msbA mutant
(Fig. 4B). The results presented here are comparable with those
obtained earlier with the lpxA (9) and imp (11) mutants. In conclusion,
it appeared that themsbAmutant is still able to assemble an OM, dem-
onstrating that PL transport is not compromised in themsbAmutant.
Like E. coli,N. meningitidiswas reported to produce large amounts of
phosphatidylethanolamine and PG, but, in contrast to E. coli, it pro-
duces only trace amounts of CL and substantial amounts of phospha-
tidic acid (PA) (29). To investigate whether all major PL species are still
produced in the msbA mutant, cells from strain HB-1 and its msbA
mutant derivative were labeled with [14C]sodium acetate, and PL were
extracted and analyzed by TLC (Fig. 5A). All major PL species were
detected in themsbAmutant, although the relative amounts of PG and
PA/CL (PA andCL are not separated on theTLC systemused) appeared
to be different (Fig. 5A). Quantification of the radioactive spots revealed
that the relative amount of PGwas decreased from 17% in the wild-type
strain to 8.4–8.6% in themsbAmutant, whereas the relative amount of
PA/CL was increased from 7% in the wild-type strain to 12.2–14.6% in
the msbA mutant as determined in two independent experiments. A
similar change in the relative amounts of PGandPA/CLwas observed in
both the imp and the lpxAmutant of N. meningitidis (data not shown).
The lack of LPS in the OM of LPS biogenesis mutants must be com-
pensated by increased amounts of other lipidic components. To inves-
tigate whether themsbAmutant produced more PL than did wild-type
cells, PLwere extracted from cells grown on plate, and their phosphorus
contentwas quantified. ThemsbAmutant derived fromwild-type strain
H44/76, which possesses a capsule, showed no increase in the total
amount of PL (data not shown). Strikingly, however, the msbAmutant
of the capsule-less strain, HB-1, showed a considerable increase in the
total amount of PL when compared with its parental strain (Fig. 5B).
Apparently, in this strain, increased PL levels compensate for the lack of
LPS, whereas in the msbA mutant of strain H44/76, the lack of LPS
FIGURE 3. LPS content in an msbA mutant. A, cells from strain H44/76 (parent), the
complemented msbA mutant, and the msbA mutant were collected after growth on
plate, and the LPS content was analyzed by Tricine-SDS-PAGE. B, KDO and protein con-
centrations were measured in cell envelopes isolated from the various H44/76 deriva-
tives indicated. The ratio of the KDO concentration divided by the protein concentration
in the wild-type strain (27 nmol KDO/mg of protein) was corrected for the background
value measured in the lpxAmutant (1.9 nmol KDO/mg of protein) and subsequently set
to 100%.
FIGURE 4.Morphology and cell envelope protein profile of anmsbAmutant. A, elec-
tronmicrographof anultrathin sectionof a cell of themsbAmutantderived fromH44/76.
The IM and OM are indicated by arrows. B, expression and assembly of PorA in strain
H44/76 (parent), and its msbA-, lpxA-, and imp-mutant derivatives. Cell envelopes were
analyzed by SDS-PAGE under denaturing (d) or semi-native (n) conditions. Gels were
blotted and probed with anti-PorA antibody. The positions of molecular mass marker
proteins are shown at the left (in kDa).
FIGURE 5. Phospholipids analysis of themsbAmutant and its parent strain. A, cells
from strain HB-1 (parent) and its msbA mutant derivative (msbA) were labeled with
[14C]acetate, and their phospholipids were isolated and analyzed by TLC. The positions
of the major PL species are indicated. PA and CL are not separated in the TLC system
used. B, cells grown on plate were resuspended, and PL were isolated from equal
amounts of cells based upon the OD550. Total PL isolations were quantified for their
phosphorus content. Mean values and standard deviations were calculated (n 6, p
0.06)with themeanphosphorus amount in thePL fractionof theparent strain (28.1nmol
Pi/OD unit) set at 100%.
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might be compensated by increased amounts of capsule, a polysaccha-
ride that is anchored via its lipid tail in the outer leaflet of the OM.
To demonstrate that the overproduced PL in themsbAmutant deriv-
ative of strain HB-1 accumulated in the OM, IM and OM were sepa-
rated on sucrose gradients, and the PL content of each fraction was
determined. However, despite many attempts, we never obtained satis-
factory membrane separations, even for the wild-type cells. Although
the IMmarker, lactate dehydrogenase, and the OMmarker, the porins,
fractionated reasonably well to lower and higher density sucrose frac-
tions, respectively, PL did not peak with these markers and were found
in every fraction of the gradient in approximately equal amounts (data
not shown). Similar problems were previously encountered for LPS
localizations (3) andmay be related to the capacity ofN. meningitidis to
shed blebs. Considering the difficulties in localizing the lipid compo-
nents even in the wild-type cells, results with the mutant cells were as a
matter of course inconclusive.
DISCUSSION
PL are synthesized at the cytoplasmic side of the IM (1). Their subse-
quent trans-bilayer movement and their transport across the aqueous
periplasm to the OM are unknown processes. It has been proposed that
theMsbA protein, which is involved in flip-flop of LPS across the IM, is
involved in the trans-bilayer movement of PL as well (2, 3). However,
this view has been challenged by the observation that MsbA reconsti-
tuted in proteoliposomes did not stimulate PL flip-flop, whereas several
other membrane-spanning -helical proteins did (7). Thus, the PL
transport defect observed in a temperature-sensitive msbA mutant of
E. coli (2, 3) may be an indirect effect, resulting from interference of PL
transport by LPS accumulating on the inner surface of the IM.
To investigate a possible direct role of MsbA in PL transport in vivo,
we decided to make use of the observation thatN. meningitidis is viable
without LPS (9). The expectation was that it would be impossible to
generate an msbA mutant if the MsbA protein had an essential role in
the transport of PL, whereas the gene could be dispensable if its product
were involved in LPS transport only.We found that anmsbA disruption
mutant could be created inN. meningitidis, thereby excluding an essen-
tial role for MsbA in PL transport.
The growth rate of the mutant was clearly affected, and the mutant
showed drastically reduced LPS levels, similarly as reported previously
for the impmutant ofN. meningitidis (11) and consistent with a role for
MsbA in LPS biogenesis. An OM was still present, and the abundant
OM protein PorA was correctly assembled, similar to the wild type. All
major PL were produced in the msbA mutant, although the relative
amount of PG appeared decreased and that of PA/CL increased. The
change in the PL profile could be a response to the loss of LPS from the
OM as the impmutant showed the same phenotype also in this respect.
In the msbA mutant derived from HB-1, which lacks a capsule, PL
were overproduced. Although we could not demonstrate that the over-
produced PL accumulated in the OM, it is conceivable that they form
the outer leaflet in the OM, thereby replacing LPS. Similarly, it has been
shown previously in E. coli that mutations in the LPS biosynthesis genes
htrB (lpxL) (30) and lpxC (31) gave rise to higher PL levels. However,
such an increase in PL content was not observed in themsbAmutant of
the capsule-producing strain H44/76. Possibly, the capsule replaces the
LPS in this strain, as proposed earlier for the lpxAmutant (32).
Interestingly, MsbA is homologous to the human multidrug resist-
ance P-glycoprotein MDR1 (33), which confers resistance to various
drugs, including lipophilic substrates. Gram-positive bacteria, including
Lactococcus lactis and Bacillus subtilis, also possess a wide range of
ATP-binding cassette transporters, including a homologue of MDR1,
designated LmrA (34), and YvcC (BmrA) (35), respectively. In the
amino acid sequence, YvcC shares 28% identity and has a 53% similarity
withE. coliMsbA,whereas LmrA shows 30% identity and 51% similarity
to E. coli MsbA. It was shown that LmrA and MsbA have overlapping
substrate specificities since expression of LmrA could functionally sub-
stitute for a temperature-sensitive mutant MsbA at the restrictive tem-
perature (36). Thus, it was proposed that LmrA, besides pumping drugs
out of the bacterium, could have a function in phospholipid transport in
L. lactis. However, the possibility to create disruption mutants of yvcC
(37) and lmrA (38) demonstrates that theseATP-binding cassette trans-
porters are not essential for PL flip-flop in these bacteria.
Our results unequivocally demonstrated that MsbA is not required
for PL transport in N. meningitidis. The msbA gene of N. meningitidis
could complement anmsbAmutant ofE. coli, indicating a similar role of
these proteins in both bacteria. Since MsbA of N. meningitidis seemed
involved in LPS transport only, this result suggested thatMsbA of E. coli
may not be required for PL transport either. The accumulation of PL in
the IM observed in such an E. colimutant at the restrictive temperature
(2) could then be explained as a secondary effect of the defective LPS
transport. However, the possibilities that the functions of E. coli and
N. meningitidis MsbA overlap only partially or that the MsbA has a
redundant function in PL transport inN. menigitidis cannot entirely be
excluded at this stage.
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